Literature DB >> 35758827

HIV and Incarceration: Implications for HIV-Positive People Who Use Illicit Drugs During a Seek, Test, Treat, and Retain Initiative in Canada.

Ezequiel Blumenkrans1, Jonah Hamilton1, N A Mohd Salleh1, Angela Kaida2, Will Small1,2, Rolando Barrios3, M-J Milloy1,4.   

Abstract

People who use illicit drugs (PWUD) face increased exposure to the criminal justice system and disproportionate burdens of HIV infection. This article investigated the effects of incarceration on HIV cascade of care-related measures in a setting with a community-wide seek, test, treat, and retain (STTR) initiative. Using a multivariable logistic regression analysis of 935 HIV-positive PWUD between 2005 and 2017, this article showed a negative relationship between periods of incarceration and two measures of engagement in clinical care for HIV among PWUD: recent dispensation of antiretroviral therapy and suppression of HIV viral load. These findings suggest the benefits of STTR-based efforts are limited by exposure to the criminal justice system and highlight the need for additional supports for PWUD with HIV exposed to the criminal justice system.

Entities:  

Keywords:  HIV; antiretroviral therapy; harm reduction; incarceration; people who use drugs

Mesh:

Substances:

Year:  2022        PMID: 35758827      PMCID: PMC9529366          DOI: 10.1089/jchc.20.04.0021

Source DB:  PubMed          Journal:  J Correct Health Care        ISSN: 1078-3458


  30 in total

Review 1.  HIV treatment as prevention among injection drug users.

Authors:  Evan Wood; Michael John Milloy; Julio S G Montaner
Journal:  Curr Opin HIV AIDS       Date:  2012-03       Impact factor: 4.283

Review 2.  The effectiveness of opioid maintenance treatment in prison settings: a systematic review.

Authors:  Dagmar Hedrich; Paula Alves; Michael Farrell; Heino Stöver; Lars Møller; Soraya Mayet
Journal:  Addiction       Date:  2012-03       Impact factor: 6.526

3.  Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy.

Authors:  Duncan Smith-Rohrberg Maru; R Douglas Bruce; Mary Walton; Jo Anne Mezger; Sandra A Springer; David Shield; Frederick L Altice
Journal:  AIDS Behav       Date:  2007-12-18

Review 4.  The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis.

Authors:  Princess A Iroh; Helen Mayo; Ank E Nijhawan
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

5.  Simulation study of confounder-selection strategies.

Authors:  G Maldonado; S Greenland
Journal:  Am J Epidemiol       Date:  1993-12-01       Impact factor: 4.897

6.  Adherence to Antiretroviral Therapy Among Incarcerated Persons with HIV: Associations with Methadone and Perceived Safety.

Authors:  Gabriel J Culbert; Agung Waluyo; Melinda Wang; Tissa Aulia Putri; Alexander R Bazazi; Frederick L Altice
Journal:  AIDS Behav       Date:  2019-08

7.  Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.

Authors:  M-J Milloy; Thomas Kerr; Jane Buxton; Tim Rhodes; Andrea Krusi; Silvia Guillemi; Robert Hogg; Julio Montaner; Evan Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

8.  Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users.

Authors:  M J Milloy; Thomas Kerr; Jane Buxton; Tim Rhodes; Silvia Guillemi; Robert Hogg; Julio Montaner; Evan Wood
Journal:  J Infect Dis       Date:  2011-05-01       Impact factor: 5.226

9.  Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.

Authors:  Kate A Dolan; James Shearer; Bethany White; Jialun Zhou; John Kaldor; Alex D Wodak
Journal:  Addiction       Date:  2005-06       Impact factor: 6.526

10.  Incarceration of people living with HIV/AIDS: implications for treatment-as-prevention.

Authors:  M-J Milloy; Julio S G Montaner; Evan Wood
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.